CDC vaccine schedule change raises clinician concerns

A report supporting the CDC's revisions says the U.S. is an outlier in the number of diseases and the total number of vaccine doses recommended in its pediatric vaccine schedule. But some physician groups say comparisons to other countries can be misguided and removing vaccines from the schedule puts children's health at risk.

Editor's Pick

Top Story CDC Removal of Six Diseases From Child Vaccination Schedule Sparks Concern From Clinicians A report supporting the CDC's revisions says the U.S. is an outlier in the number of diseases and the total number of vaccine doses recommended in its pediatric vaccine schedule. But some physician groups say comparisons to other countries can be misguided and removing vaccines from the schedule puts children's health at risk. Sponsored Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health Presented by Esperion Heart disease remains the leading cause of death in the US and worldwide—for both men and women. Esperion is offering a variety of educational tools for both healthcare providers and patients to raise awareness about statin intolerance and alternative treatments.  Learn More

Featured News

Color Health Partners With Evry Health to Expand Access to Virtual Cancer Care Color Health is partnering with insurer Evry Health to offer its virtual cancer clinic to employer health plan members. J.P. Morgan Report: Obesity & Diabetes Dealmaking Set a New Record in 2025 Obesity and diabetes drug R&D partnerships struck in 2025 represented $20.2 billion in total deal value, a new record high, according to a new report from J.P. Morgan. While IPO activity and venture investment trended downward, M&A activity was significantly higher. OpenAI Launches ChatGPT Health: 5 Things to Know OpenAI announced a new dedicated platform for health conversations. The company said the new offering is not intended for medical diagnosis or treatment — but rather to provide support for personal health navigation. GSK Gets Closer to Bringing Patients a Functional Cure for Chronic Hepatitis B GSK's bepirovirsen met the main goal of two Phase 3 studies, achieving functional cure rates for patients with chronic hepatitis B infection after six months of treatment. This antisense oligonucleotide therapy could provide a treatment alternative to antiviral drugs that patients must take for life. The GLP-1 Revolution: Medical Aesthetics And The Coming Battle For Control The same forces now at play in medical aesthetics will soon appear in every therapeutic category where treatment overlaps with identity, from hormones to nootropics to genetic optimization. The Weight Loss Market in 2026: 3 Questions That Will Shape the Next Decade The weight loss market is at yet another inflection point. The euphoria of the past three years is now confronting the realities of how obesity medications will scale to address an epidemic that impacts over 1 billion people globally.

Video   How Oura is moving beyond wellness Oura is no longer just a sleep-focused wellness startup. It's getting deeper into chronic disease management and healthcare integration, said its chief medical officer, Ricky Bloomfield.

Sponsored How and Where to Apply for a Covered California Health Insurance Plan Presented by Health for California The marketplace allows you to compare standardized plans, access subsidies and enroll with confidence. Using a certified enrollment partner, such as Health for California, ensures that your application is accurate, supported and submitted through an authorized channel. Learn More

Resources

MedCity FemFwd: The Importance of Virtual Maternal-Fetal Medicine In this episode, we're joined by Dr. Blake Porter, chief of maternal-fetal medicine with Access TeleCare. He discusses the need to expand access to virtual maternal-fetal medicine care. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe